These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 20307216

  • 1. Aqueous humor concentrations of bimatoprost free acid, bimatoprost and travoprost free acid in cataract surgical patients administered multiple topical ocular doses of LUMIGAN or TRAVATAN.
    Faulkner R, Sharif NA, Orr S, Sall K, Dubiner H, Whitson JT, Moster M, Craven ER, Curtis M, Pailliotet C, Martens K, Dahlin D.
    J Ocul Pharmacol Ther; 2010 Apr; 26(2):147-56. PubMed ID: 20307216
    [Abstract] [Full Text] [Related]

  • 2. Detection of the free acid of bimatoprost in aqueous humor samples from human eyes treated with bimatoprost before cataract surgery.
    Camras CB, Toris CB, Sjoquist B, Milleson M, Thorngren JO, Hejkal TW, Patel N, Barnett EM, Smolyak R, Hasan SF, Hellman C, Meza JL, Wax MB, Stjernschantz J.
    Ophthalmology; 2004 Dec; 111(12):2193-8. PubMed ID: 15582073
    [Abstract] [Full Text] [Related]

  • 3. Comparison of human ocular distribution of bimatoprost and latanoprost.
    Ichhpujani P, Katz LJ, Hollo G, Shields CL, Shields JA, Marr B, Eagle R, Alvim H, Wizov SS, Acheampong A, Chen J, Wheeler LA.
    J Ocul Pharmacol Ther; 2012 Apr; 28(2):134-45. PubMed ID: 22136089
    [Abstract] [Full Text] [Related]

  • 4. Human trabecular meshwork cell responses induced by bimatoprost, travoprost, unoprostone, and other FP prostaglandin receptor agonist analogues.
    Sharif NA, Kelly CR, Crider JY.
    Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):715-21. PubMed ID: 12556403
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The effect of latanoprost, bimatoprost, and travoprost on circadian variation of intraocular pressure in patients with open-angle glaucoma.
    Yildirim N, Sahin A, Gultekin S.
    J Glaucoma; 2008 Feb; 17(1):36-9. PubMed ID: 18303382
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Levels of bimatoprost acid in the aqueous humour after bimatoprost treatment of patients with cataract.
    Cantor LB, Hoop J, Wudunn D, Yung CW, Catoira Y, Valluri S, Cortes A, Acheampong A, Woodward DF, Wheeler LA.
    Br J Ophthalmol; 2007 May; 91(5):629-32. PubMed ID: 17135335
    [Abstract] [Full Text] [Related]

  • 10. Mechanism of ocular hypotensive action of bimatoprost (Lumigan) in patients with ocular hypertension or glaucoma.
    Christiansen GA, Nau CB, McLaren JW, Johnson DH.
    Ophthalmology; 2004 Sep; 111(9):1658-62. PubMed ID: 15350319
    [Abstract] [Full Text] [Related]

  • 11. Duration of IOP reduction with travoprost BAK-free solution.
    Gross RL, Peace JH, Smith SE, Walters TR, Dubiner HB, Weiss MJ, Ochsner KI.
    J Glaucoma; 2008 Sep; 17(3):217-22. PubMed ID: 18414108
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of travoprost on aqueous humor dynamics in patients with elevated intraocular pressure.
    Toris CB, Zhan G, Fan S, Dickerson JE, Landry TA, Bergamini MV, Camras CB.
    J Glaucoma; 2007 Mar; 16(2):189-95. PubMed ID: 17473728
    [Abstract] [Full Text] [Related]

  • 14. Intraocular pressure-lowering efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension.
    Cantor LB, Hoop J, Morgan L, Wudunn D, Catoira Y, Bimatoprost-Travoprost Study Group.
    Br J Ophthalmol; 2006 Nov; 90(11):1370-3. PubMed ID: 16825272
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Real-time intracellular Ca2+ mobilization by travoprost acid, bimatoprost, unoprostone, and other analogs via endogenous mouse, rat, and cloned human FP prostaglandin receptors.
    Kelly CR, Williams GW, Sharif NA.
    J Pharmacol Exp Ther; 2003 Jan; 304(1):238-45. PubMed ID: 12490597
    [Abstract] [Full Text] [Related]

  • 17. Prostaglandin analogs and blood-aqueous barrier integrity: a flare cell meter study.
    Cellini M, Caramazza R, Bonsanto D, Bernabini B, Campos EC.
    Ophthalmologica; 2004 Jan; 218(5):312-7. PubMed ID: 15334011
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evaluation of circadian control of intraocular pressure after a single drop of bimatoprost 0.03% or travoprost 0.004%.
    Frenkel RE, Noecker RJ, Craven ER.
    Curr Med Res Opin; 2008 Apr; 24(4):919-23. PubMed ID: 18267054
    [Abstract] [Full Text] [Related]

  • 20. The effects of prostaglandin analogues on IOP in prostanoid FP-receptor-deficient mice.
    Ota T, Aihara M, Narumiya S, Araie M.
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4159-63. PubMed ID: 16249494
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.